Parkinson’s disease is a degenerative disorder of movement that occurs due to dopamine deficiency in the basal ganglia. Antiparkinson agents attempt to replace dopamine and treat or halt the symptoms such as tremor, hypokinesia, and so on.
Anti-Parkinson’s drugs are mainly used to treat Parkinson’s disease. They are not psychiatric drugs, which means they are not licensed to treat mental health problems. These anti-Parkinson’s drugs are sometimes known as antimuscarinics. Antimuscarinic is the term used for the group of effects that these drugs have on your body.